Nkarta (NKTX) Change in Accured Expenses (2019 - 2026)

Nkarta's (NKTX) quarterly Change in Accured Expenses came in at -$3.9 million in Q1 2026, down 2117.71% year-on-year from $192000.0 in Q1 2025, and down 253.37% quarter-over-quarter from $2.5 million in Q4 2025.

Nkarta (NKTX) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Nkarta's Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$3.9 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 2117.71% year-over-year to -$3.9 million in Q1 2026; TTM through Mar 2026 was -$1.6 million, a 29.9% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, up 155.11% from the prior year.
  • Change in Accured Expenses retreated to -$3.9 million in Q1 2026 per NKTX's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $4.6 million in Q3 2022 and bottomed at -$3.9 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is $192000.0 (2025), against an average of $64705.9.
  • Across the five-year window, Change in Accured Expenses soared 285.08% in 2023 and plunged 2117.71% in 2026, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$619000.0 in 2022, then surged by 196.28% to $596000.0 in 2023, then slumped by 512.08% to -$2.5 million in 2024, then surged by 202.85% to $2.5 million in 2025, then tumbled by 253.37% to -$3.9 million in 2026.
  • Per Business Quant, the three latest NKTX Change in Accured Expenses figures stand at -$3.9 million (Q1 2026), $2.5 million (Q4 2025), and $448000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 69,146.49 Bn 69,146.20 Bn - 1.13 Mn
2 Nanobiotix 1,942.19 Bn 1,942.13 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - 931,000.00
4 BeOne Medicines 475.42 Bn 470.63 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 123.32 Bn 116.08 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.80 Bn 61.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 63.28 Bn 63.28 Bn - -
8 Argenx Se 56.67 Bn 51.48 Bn 1.41 Bn -
9 Revolution Medicines 38.15 Bn 38.15 Bn - -16.74 Mn
10 Nkarta 178.96 Mn 178.96 Mn - -3.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.87 Mn
Mar 31, 2026 -3.87 Mn
Dec 31, 2025 2.53 Mn
Dec 31, 2025 2.53 Mn
Sep 30, 2025 448,000.00
Sep 30, 2025 448,000.00
Jun 30, 2025 -703,000.00
Jun 30, 2025 -703,000.00
Mar 31, 2025 192,000.00
Mar 31, 2025 192,000.00
Dec 31, 2024 -2.46 Mn
Dec 31, 2024 -2.46 Mn
Sep 30, 2024 130,000.00
Sep 30, 2024 130,000.00
Jun 30, 2024 900,000.00
Jun 30, 2024 900,000.00
Mar 31, 2024 -3.04 Mn
Mar 31, 2024 -3.04 Mn
Dec 31, 2023 596,000.00
Dec 31, 2023 596,000.00